Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review (Q33675546)

28 July 2017

1 reference

26 August 2022

1 reference

title

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review (English)

1 reference

ventilator-associated pneumonia

28 July 2017

1 reference

21 October 2020

1 reference

26 August 2022

Pseudomonas infection

1 reference

bacterial drug resistance

4 August 2019

Pseudomonas aeruginosa

1 reference

2 November 2019

1 reference

7 November 2019

1 reference

11 September 2020

1 reference

21 October 2020

5

Andrew F Shorr

1 reference

28 July 2017

1

Marya D Zilberberg

1 reference

28 July 2017

4

Andrew M Ramsey

1 reference

28 July 2017

2

Joyce Chen

1 reference

28 July 2017

3

Samir H Mody

1 reference

28 July 2017

publication date

26 August 2010

12 references

28 July 2017

28 February 2019

23 March 2019

22 June 2019

4 August 2019

20 August 2019

17 September 2019

2 November 2019

7 November 2019

11 September 2020

21 October 2020

26 August 2022

BMC Pulmonary Medicine

12 references

28 July 2017

28 February 2019

23 March 2019

22 June 2019

4 August 2019

20 August 2019

17 September 2019

2 November 2019

7 November 2019

11 September 2020

21 October 2020

26 August 2022

10

1 reference

28 July 2017

page(s)

45

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

11 references

28 February 2019

23 March 2019

22 June 2019

4 August 2019

20 August 2019

17 September 2019

2 November 2019

7 November 2019

11 September 2020

21 October 2020

on focus list of Wikimedia project

26 August 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Trends in antimicrobial drug development: implications for the future

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Colistin: an antimicrobial for the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Quinolones for treatment of nosocomial pneumonia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-10-45

Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939581

Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections

30 October 2018

1 reference

12 December 2020

Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients

1 reference

12 December 2020

Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin

1 reference

12 December 2020

Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia

1 reference

12 December 2020

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

12 December 2020

Pharmacokinetics of aztreonam and imipenem in critically ill patients with pneumonia

1 reference

12 December 2020

Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients

1 reference

12 December 2020

Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial

1 reference

12 December 2020

Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital

1 reference

12 December 2020

Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups

1 reference

12 December 2020

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

1 reference

12 December 2020

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

1 reference

12 December 2020

Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia

1 reference

12 December 2020

Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone

1 reference

12 December 2020

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

12 December 2020

Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience

1 reference

12 December 2020

Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study

1 reference

12 December 2020

Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia

1 reference

12 December 2020

The business of developing antibacterials

1 reference

12 December 2020

Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia

1 reference

12 December 2020

Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans

1 reference

12 December 2020

Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2466-10-45

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference